Acute upper respiratory infections (URIs) represent a common group of illnesses affecting the upper respiratory tract, including the nose, throat, and sinuses. These infections are typically caused by viruses, such as rhinoviruses, coronaviruses, influenza viruses, and adenoviruses. Common symptoms of acute URIs include nasal congestion, runny nose, sneezing, sore throat, coughing, and sometimes fever. The majority of acute URIs are self-limiting and resolve without specific medical treatment. Supportive care, including rest, hydration, and over-the-counter medications for symptom relief, is often recommended. Antiviral medications may be prescribed in certain cases, such as influenza infections. Antibiotics are not effective against viral URIs and are reserved for bacterial infections, which are less common. Preventive measures for acute URIs include practicing good hand hygiene, avoiding close contact with infected individuals, and getting vaccinated against influenza. While these infections are usually mild, they can cause more severe complications in certain populations, such as the elderly, young children, or individuals with underlying health conditions.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain